# Dynex Capital Inc: financial statements, quarterly

DX · NYSE · CIK 826675 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dx.md) · [Financials](/companies/dx/financials.md) · [Filings](/companies/dx/filings.md) · [Insiders](/companies/dx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [65.5](/filings/0000826675-23-000107.md) | [73.5 d](/filings/0000826675-24-000011.md) | [74.7](/filings/0000826675-24-000051.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(43.1)](/filings/0000826675-24-000128.md) | [24.3 d](/filings/0000826675-26-000017.md) | [40.1](/filings/0000826675-25-000056.md) | [(8.3)](/filings/0000826675-25-000118.md) | [31.0](/filings/0000826675-25-000153.md) | [51.1 d](/filings/0000826675-26-000017.md) | [(3.1)](/filings/0000826675-26-000039.md) | [(13.6)](/filings/0000826675-26-000078.md) | [150](/filings/0000826675-25-000153.md) | [185 d](/filings/0000826675-26-000017.md) | [(80.4)](/filings/0000826675-26-000039.md) | [181](/filings/0000826675-26-000078.md) |
| Diluted EPS | $ per share | [(0.82)](/filings/0000826675-24-000128.md) | not reported | [0.64](/filings/0000826675-25-000056.md) | [(0.15)](/filings/0000826675-25-000118.md) | [0.38](/filings/0000826675-25-000153.md) | not reported | [(0.06)](/filings/0000826675-26-000039.md) | [(0.14)](/filings/0000826675-26-000078.md) | [1.08](/filings/0000826675-25-000153.md) | not reported | [(0.41)](/filings/0000826675-26-000039.md) | [0.80](/filings/0000826675-26-000078.md) |
| Basic EPS | $ per share | [(0.82)](/filings/0000826675-24-000128.md) | not reported | [0.65](/filings/0000826675-25-000056.md) | [(0.15)](/filings/0000826675-25-000118.md) | [0.38](/filings/0000826675-25-000153.md) | not reported | [(0.06)](/filings/0000826675-26-000039.md) | [(0.14)](/filings/0000826675-26-000078.md) | [1.09](/filings/0000826675-25-000153.md) | not reported | [(0.41)](/filings/0000826675-26-000039.md) | [0.80](/filings/0000826675-26-000078.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0000826675-23-000107.md) | [0.1](/filings/0000826675-25-000021.md) | [0.3](/filings/0000826675-24-000051.md) | [0.3](/filings/0000826675-24-000093.md) | [0.3](/filings/0000826675-24-000128.md) | [0.4](/filings/0000826675-26-000017.md) | [0.3](/filings/0000826675-25-000056.md) | [0.4](/filings/0000826675-25-000118.md) | [0.5](/filings/0000826675-25-000153.md) | [0.5](/filings/0000826675-26-000078.md) | [0.8](/filings/0000826675-26-000039.md) | [0.6](/filings/0000826675-26-000078.md) |
| Total assets | $bn | [6.0](/filings/0000826675-23-000107.md) | [6.4](/filings/0000826675-25-000021.md) | [6.3](/filings/0000826675-24-000051.md) | [6.7](/filings/0000826675-24-000093.md) | [7.8](/filings/0000826675-24-000128.md) | [8.2](/filings/0000826675-26-000017.md) | [9.0](/filings/0000826675-25-000056.md) | [11.3](/filings/0000826675-25-000118.md) | [14.2](/filings/0000826675-25-000153.md) | [17.3](/filings/0000826675-26-000078.md) | [24.3](/filings/0000826675-26-000039.md) | [26.4](/filings/0000826675-26-000078.md) |
| Total liabilities | $bn | [5.2](/filings/0000826675-23-000107.md) | [5.5](/filings/0000826675-25-000021.md) | [5.3](/filings/0000826675-24-000051.md) | [5.6](/filings/0000826675-24-000093.md) | [6.7](/filings/0000826675-24-000128.md) | [7.0](/filings/0000826675-26-000017.md) | [7.6](/filings/0000826675-25-000056.md) | [9.7](/filings/0000826675-25-000118.md) | [12.2](/filings/0000826675-25-000153.md) | [14.9](/filings/0000826675-26-000078.md) | [21.6](/filings/0000826675-26-000039.md) | [23.2](/filings/0000826675-26-000078.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.8](/filings/0000826675-24-000128.md) | [0.9](/filings/0000826675-26-000017.md) | [1.0](/filings/0000826675-25-000118.md) | [1.0](/filings/0000826675-25-000153.md) | [1.1](/filings/0000826675-25-000153.md) | [1.2](/filings/0000826675-26-000078.md) | [1.4](/filings/0000826675-26-000078.md) | [1.6](/filings/0000826675-26-000078.md) | [2.0](/filings/0000826675-25-000153.md) | [2.5](/filings/0000826675-26-000078.md) | [2.7](/filings/0000826675-26-000078.md) | [3.2](/filings/0000826675-26-000078.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.4 d](/filings/0000826675-24-000128.md) | [16.6 d](/filings/0000826675-26-000017.md) | [(17.1)](/filings/0000826675-25-000056.md) | [18.6 d](/filings/0000826675-25-000118.md) | [(2.3) d](/filings/0000826675-25-000153.md) | [15.1 d](/filings/0000826675-26-000017.md) | [6.4](/filings/0000826675-26-000039.md) | [31.9 d](/filings/0000826675-26-000078.md) | [68.3 d](/filings/0000826675-25-000153.md) | [14.3 d](/filings/0000826675-26-000017.md) | [69.8](/filings/0000826675-26-000039.md) | [84.1 d](/filings/0000826675-26-000078.md) |
| Dividends paid | $m | [23.1 d](/filings/0000826675-24-000128.md) | [24.0 d](/filings/0000826675-26-000017.md) | [24.9](/filings/0000826675-25-000056.md) | [27.0 d](/filings/0000826675-25-000118.md) | [31.2 d](/filings/0000826675-25-000153.md) | [34.8 d](/filings/0000826675-26-000017.md) | [41.6](/filings/0000826675-26-000039.md) | [56.6 d](/filings/0000826675-26-000078.md) | [69.6 d](/filings/0000826675-25-000153.md) | [78.8 d](/filings/0000826675-26-000017.md) | [103](/filings/0000826675-26-000039.md) | [113 d](/filings/0000826675-26-000078.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.3](/filings/0000826675-23-000107.md) | [53.8](/filings/0000826675-24-000051.md) | [54.6](/filings/0000826675-24-000093.md) | [54.6](/filings/0000826675-24-000128.md) | [59.7](/filings/0000826675-25-000056.md) | [67.0](/filings/0000826675-25-000118.md) | [76.4](/filings/0000826675-25-000153.md) | [90.5](/filings/0000826675-26-000039.md) | [113](/filings/0000826675-26-000078.md) | [137](/filings/0000826675-25-000153.md) | [200](/filings/0000826675-26-000039.md) | [224](/filings/0000826675-26-000078.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 247,429,551 at 2026-07-24, from the cover of the [10-Q filed 2026-07-27](/filings/0000826675-26-000078.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.